Regression of left ventricular hypertrophy during treatment with antihypertensive agents
- PMID: 37879
- PMCID: PMC1429326
- DOI: 10.1111/j.1365-2125.1979.tb04698.x
Regression of left ventricular hypertrophy during treatment with antihypertensive agents
Abstract
1 Echocardiography showed 14 of 24 patients with essential hypertension to have hypertrophy of their left ventricular walls. In eight of these 14 patients the left ventricular configuration initially fulfilled the criteria for asymmetric septal hypertrophy (ASH) and six were symmetrically hypertrophied, the remaining ten being normal. 2 Following 12 weeks' treatment of hypertension with the object of reducing the supine BP to 150/90 mmHg or below, there was a reduction of wall thickness so that only two of the eight continued to show ASH. 3 The six patients with symmetrical left ventricular hypertrophy also showed a significant reduction in the thickness of the septum and the posterior wall. Those with normal echocardiograms did not change. 4 This reduction of wall thickness produced by antihypertensive therapy may represent regression of left ventricular hypertrophy.
Similar articles
-
Reversal of left ventricular hypertrophy following treatment with beta-blockers: experience with tertatolol.Am J Nephrol. 1986;6 Suppl 2:94-9. doi: 10.1159/000167341. Am J Nephrol. 1986. PMID: 2879479
-
The correlation of changes in systolic blood pressure with regional anatomical regression of hypertensive left ventricular hypertrophy in patients on chronic antihypertensive therapy (greater than 1 year): alpha-methyldopa compared to propranolol.Curr Med Res Opin. 1984;8(10):720-33. doi: 10.1185/03007998409110123. Curr Med Res Opin. 1984. PMID: 6233093 Clinical Trial.
-
Left ventricular hypertrophy regression during antihypertensive treatment.Clin Investig. 1992;70 Suppl 1:S79-86. doi: 10.1007/BF00207616. Clin Investig. 1992. PMID: 1350490 Clinical Trial.
-
Regression of left ventricular hypertrophy in hypertension with alpha-adrenergic blockade: physiological basis and therapeutic implications.J Hypertens Suppl. 1989 Dec;7(6):S98-9. doi: 10.1097/00004872-198900076-00045. J Hypertens Suppl. 1989. PMID: 2576672 Review.
-
Effects of antihypertensive therapy on diastolic dysfunction in left ventricular hypertrophy.J Cardiovasc Pharmacol. 1992;19 Suppl 5:S116-21. J Cardiovasc Pharmacol. 1992. PMID: 1381787 Review.
Cited by
-
Comparison between the effects of urapidil and methyldopa on left ventricular hypertrophy and haemodynamics in humans.Drugs. 1988;35 Suppl 6:90-7. doi: 10.2165/00003495-198800356-00013. Drugs. 1988. PMID: 2969799 Clinical Trial.
-
Relationship between hypertension and angina pectoris.Br J Clin Pharmacol. 1979;7 Suppl 2(Suppl 2):249S-253S. doi: 10.1111/j.1365-2125.1979.tb04697.x. Br J Clin Pharmacol. 1979. PMID: 157148 Free PMC article.
-
Treatment of essential hypertension: changes in blood pressure, echocardiography and electrocardiography on three therapeutic regimes.Eur J Clin Pharmacol. 1985;28(2):119-24. doi: 10.1007/BF00609677. Eur J Clin Pharmacol. 1985. PMID: 3157577 Clinical Trial.
-
Left ventricular hypertrophy and antihypertensive therapy.Drugs. 1988;35 Suppl 5:27-33. doi: 10.2165/00003495-198800355-00004. Drugs. 1988. PMID: 2975215 Review.
-
Effect of beta-blockade on exercise capacity in hypertensive subjects: a one-year double-blind study of celiprolol and metoprolol.Cardiovasc Drugs Ther. 1995 Feb;9(1):133-9. doi: 10.1007/BF00877753. Cardiovasc Drugs Ther. 1995. PMID: 7786833 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous